Lasa Supergenerics Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 243.03 million compared to INR 336.61 million a year ago. Revenue was INR 243.87 million compared to INR 336.65 million a year ago. Net loss was INR 0.228 million compared to INR 66.07 million a year ago.
For the six months, sales was INR 548.59 million compared to INR 625.4 million a year ago. Revenue was INR 549.46 million compared to INR 625.53 million a year ago. Net loss was INR 49.72 million compared to INR 186.91 million a year ago. Basic loss per share from continuing operations was INR 0.99 compared to INR 4.6 a year ago. Diluted loss per share from continuing operations was INR 0.99 compared to INR 4.6 a year ago.